| Artificial colonization of clumping factor B deficient Staphylococcus aureus in the nose |
| assessment of efficacy |
| assessment of gene interaction |
| assessment of gene stability |
| assessment of safety |
| assessment of survival, persistence and dispersal |
| assessment of viral fitness |
| biocontrol of tomato bacterial wilt |
| bioinsecticide |
| biological containment |
| bioluminescence |
| Clinical testing cancer therapy |
| Clinical trials |
| Field test of sensor based luminescence |
| gene detection |
| gene therapy |
| increase of nodulation competitiveness |
| interaction studies |
| marker system |
| metabolism of lactose |
| Monitoring of biocontrol of fungal pathogens |
| Monitoring of health effects to transgenic animals due to exposure |
| pollution tracing |
| reduced survival |
| resistance to fungi |
| Safety evaluation and immunogenicity of a candidate oral immunotherapy |
| secretion of alpha-amylase |
| soil bioremediation |
| synthesis of 2,4 diacetyl-phloroglucinol |
| synthesis of a vaccine |
| synthesis of chitinase |
| synthesis of fungicide |
| synthesis of human p53 tumor suppressor gene product |
| synthesis of hydrogenase |
| synthesis of phenazine-1-carboxylic acid |
| synthesis of phluoroglucynol |
| Vaccine testing |
